UCSF Department of Radiology & Biomedical Imaging press release
A research team from UCSF, UC Berkeley and 3D Printer Carbon, Inc. have created a drug sponge to absorb excess chemotherapy medication. The sponge is being designed so that after the chemotherapy has gone through the tumor, the part that hasn't treated the tumor could bind to the device, absorbing the excess dose like a "drug sponge." At the end of the procedure, the device is removed from the body, preventing the spread of toxicity throughout the body. "
By Anne Wärme Lykke |Technical University of Denmark
Now, researchers from the Department of Energy's Joint BioEnergy Institute (JBEI), Berkeley Lab, and the Novo Nordisk Foundation Center for Biosustainability at Technical University of Denmark (DTU Biosustain) have found a way to engineer the fatty membranes of cells. The researchers boosted the cells' ability to produce high amounts of fluid fats, so-called unsaturated lipids. This increased the membrane respiration as well as the cellular growth rate.
Over the past 150 years, UC Berkeley has been at the forefront of scientific discovery, achieving milestones that have impacted both the research industry and the surrounding community.
Notable figures and facilities across campus have engaged in and continue to engage in progressing the scientific realm of society, whether it be founding modern statistical theory, producing plutonium...
A research team from UCSF, UC Berkeley and 3D Printer Carbon, Inc. have created a drug sponge to absorb excess chemotherapy medication. The sponge is being designed so that after the chemotherapy has gone through the tumor, the part that hasn't treated the tumor could bind to the device, absorbing the excess dose like a "drug sponge." At the end of the procedure, the device is removed from the body, preventing the spread of toxicity throughout the body. "
Over the past 150 years, UC Berkeley has been at the forefront of scientific discovery, achieving milestones that have impacted both the research industry and the surrounding community.
Dr. Ramelmeier discusses the future needs of talent in the biomanufacturing industry.